NCI Frederick National Lab manufactures CAR T cells for multicenter trials March 19, 2021Vol.47 No.11By Alexandria Carolan
NCI NCI raises paylines, commemorates 50th anniversary of the National Cancer Act of 1971 February 12, 2021Vol.47 No.06By Alexandria Carolan and Matthew Bin Han Ong
NCI Sharpless: “This is one of the most uncertain budget environments that I think the NCI has ever experienced.” December 04, 2020Vol.46 No.45By Alexandria Carolan
NCI Ned Sharpless: “Nothing will stop us”—NCI commemorates 50th anniversary of the National Cancer Act October 16, 2020Vol.46 No.39By Alexandria Carolan
COVID-19 & CancerFreeNCI Sharpless: COVID-19 expected to increase mortality by at least 10,000 deaths from breast and colorectal cancers over 10 years June 19, 2020Vol.46 No.25By Matthew Bin Han Ong
COVID-19 & CancerFreeNCI Sharpless: COVID-19 threatens to reverse long-running trend of decreasing cancer mortality May 15, 2020Vol.46 No.20By Matthew Bin Han Ong
COVID-19 & CancerFreeNCI Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response April 14, 2020Vol.46 No.16By Matthew Bin Han Ong
NCI Sharpless addresses three big issues in cancer in 2020:1. NCI grantees are prime targets for foreign influence, 2. Treatment seems to drive drop in lung cancer deaths, 3. RPG paylines to rise from 8% to 10% February 14, 2020Vol.46 No.07By Matthew Bin Han Ong
NCI Sharpless reflects on his time at FDA: “The engine producing new cancer therapies and diagnostics is doing very well” December 06, 2019Vol.45 No.45By Matthew Bin Han Ong
NCI Lowy: NCI needs 15% budget increase to reach FY2021 goal of 15th percentile for paylines September 06, 2019Vol.45 No.33By Matthew Bin Han Ong
